膀胱癌の既往歴を有する患者の経過観察のための新規マルチプレックスELISAアッセイ

基本情報

NCT ID

NCT03193515

ステータス

募集中

試験のフェーズ

-

試験タイプ

観察

目標被験者数

300

治験依頼者名

Cedars-Sinai Medical Center

概要

Voided urinary cytology (VUC) is the most widely used urine-based assay for detecting bladder cancer (BCa); however, it fails to detect approximately 50% of low-grade or early stage BCa when it is most curable. Furthermore, the detection rate of VUC for recurrent BCa is not much better. Because of this severe limitation, all patients who are under surveillance to monitor for recurrent BCa must undergo an invasive examination of the urinary bladder, where a miniature camera is inserted into the bladder and the bladder inspected (cystoscopy). We propose to improve the non-invasive detection of recurrent BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples.

対象疾患

依頼者（Sponsor）

実施施設 (1)